LEADER 01457nam  22005175u 450 
001 9910156316603321
005 20211006145426.0
010   $a9783318034103
010   $a331803410X
035   $a(CKB)3780000000102265
035   $a(OCoLC)1046109921
035   $a(SZ-BaSKA)221278
035   $a(MiAaPQ)EBC31865169
035   $a(Au-PeEL)EBL31865169
035   $a(EXLCZ)993780000000102265
100   $a20211006d1987      uy         0
101 0 $aeng
135   $aurunu|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aTumor Therapy with Tumor Cells and Neuraminidase : $eCell Physiological, Immunological, and Oncological Aspects / $f H.H. Sedlacek
205   $a1st ed.
210   $aBasel : $cS. Karger, $d1987
215   $a1 online resource (VIII + 96 pages) : $c  19 tables
225 1 $aIssn Series
311 08$a9783805545495 
311 08$a3805545495 
410  0$aIssn Series
606   $aOncology
606   $aBiochemistry
606   $aImmunology
606   $aInternal Medicine
606   $aSurgery
615 14$aOncology
615 14$aBiochemistry
615 14$aImmunology
615 24$aInternal Medicine
615 24$aSurgery
700   $aSedlacek$b H.H$01215120
801  0$bUKSKG
801  1$bUKSKG
906   $aBOOK
912   $a9910156316603321
996   $aTumor Therapy with Tumor Cells and Neuraminidase$92809088
997   $aUNINA